Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to identify and analyze cyclosporin compounds and their structures effectively.

Topical 1% sildenafil is not recommended for treating alopecia areata in children.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Green algae can break down finasteride, reducing environmental harm.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The treatment was effective for the puppy's skin and intestinal infections.

Strontium ranelate is no longer available for treatment.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A special clotrimazole varnish cured a siamang's persistent skin infection after 3 months.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

ALRN-6924 may prevent hair loss caused by chemotherapy.